Skip to main content

Tweets

I saw an AARP article on the "best mattresses for Fibromyalgia"!! A mattress (unless you have a really bad, saggy one) will not fix FM. Focus on sleep habits, sleep aids, pain at night and everything but the mattress!! IMHO https://t.co/MIwxpKMRih https://t.co/11J2HsL0ai
Dr. John Cush @RheumNow ( View Tweet )
10 minutes 45 seconds ago
Tokyo study of 107 pts (age: ~86y) on synov. aspiration found to have CPPD crystals - MSU crystals also seen 17 pts (16%), where CPPD crystals predominated. 7/17 had Hx of gout or hyperuricemia. None were Rx for gout. https://t.co/lDnBhd5EFA https://t.co/9DjaLHygMc
Dr. John Cush @RheumNow ( View Tweet )
2 hours 26 minutes ago
Scleroderma Research Foundation Raises Nearly $1.1 Million At This Year's Cool Comedy • Hot Cuisine event hosted by Jeff Ross & included Fortune Feimster, Matt Friend, Ron Funches, Jay Pharoah, Lisa Ann Walter, Seth Green, Howie Mandel, and John Mayer https://t.co/ktgaNNinXa https://t.co/7RhaB9li9B
Dr. John Cush @RheumNow ( View Tweet )
3 hours 39 minutes ago
THIS SATURDAY IS National Prescription Drug Take Back Day - October 24, 2026, 10AM to 2PM (safe disposal of prescription drugs) FIND a center near you >> https://t.co/gle5p0G3fC https://t.co/OBjRaTPa9B
Dr. John Cush @RheumNow ( View Tweet )
4 hours 44 minutes ago
FDA has approved NDA for Evoxac, granting Cosette right to sell oral, liquid Evoxac as an alternative treatment option for managing dry mouth symptoms in Sjögren’s patients. NA until end of 2026. https://t.co/jTySNljXMv https://t.co/PCnfAmIB2W
Dr. John Cush @RheumNow ( View Tweet )
5 hours 38 minutes ago
Portugese single center study of primary Sjögren’s dz shows early damage is assoc w/ 12-14X incr risk of lymphoma. 208 pts (F/U 14_ yrs) Damage seen in 79% & 85%. Mortality linked to age but not damage. 17 (8%) had lymphoma. Early damage incr lymphoma (HR 14.5 or HR https://t.co/g62KtjDuWg
Dr. John Cush @RheumNow ( View Tweet )
8 hours 38 minutes ago
RheumNow Live 2027 registration is NOW OPEN. GLP-1s in your clinic. CAR-T in lupus. Rheumatology experts vs. AI, with your vote. Jan. 30–31 | Onsite + virtual Early Bird Pricing through 12/15/2026. See the agenda. Register: https://t.co/zYYC2350tE https://t.co/mPdcOhbrC6
Dr. John Cush @RheumNow ( View Tweet )
22 hours 40 minutes ago
Cryptococcus is rare, but twice as likely with JAK inhibitors. Retrospective TriNetX analysis of RA pts (>30k/grp) starting JAKi vs TNFi; JAKi vs non-TNFi; & TNFi vs non-TNF. Crypto seen in <0.2% in all groups; but signif higher HR for JAKi (HR 2.2 & 2.15) https://t.co/fJeKwDZABL
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
REVEAL study enrolled 418 early microscopic polyangiitis pts - High baseline (Pre-Rx) neutrophil-to-lymphocyte ratio (NLR > 10) was assoc w/ signif higer Dz activity (BVAS), alveolar hemorrhage, poor renal function, reduced survival & higher infection-related mortality (P = https://t.co/vXuRwXP9gc
Dr. John Cush @RheumNow ( View Tweet )
1 day 2 hours ago
Polish study compared comorbidities #s in incident RA & PsA. RA pts were older at dx (61 vs 44 yrs) & may drive higher rates in RA. 23/3 comorbidities (74%) were signif more prevalent in RA, including HTN (18 v 12%), ischemic HD (11 v 6%), cerebrovascular dz (4 vs 2%) https://t.co/l0RW6bVVHd
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
FDA has granted Fast Track designation to EG-501 (Evergreen), investigational Rx for cognitive impairment with neuropsychiatric systemic lupus erythematosus (NPSLE), following positive results from the phase 2 ClearMEMory study https://t.co/n9wO2wLLBk https://t.co/Vejldj5PlQ
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
No difference in MACE risk betw TNFi vs JAKi in 6174 RA pts. Korean claims data compared TNFi (n 5,152) vs JAKi (n 1,022) initiators. MACE risk was 4.1 & 3.6/1000PYs w/ TNFi vs JAKi, respectively. MACE risk did not differ significantly between JAKi and TNFi (adj HR 0.636; 0.283, https://t.co/035WSUQAhJ
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Open Evidence study of 952 008 US clinicians (556K MDs), submitted 271 million AI clinical queries over 2.5 yrs study period. MDs submitted ~371 queries/mo - 33% for Rx & 14% fo Dx. Highest use w/ young MD, oncology, hematology, Int medicine, & family medicine https://t.co/FGErefxWD5
Dr. John Cush @RheumNow ( View Tweet )
1 day 7 hours ago
Thai study of opportunistic infx in Pediatric SLE - 177 pSLE, & 38 developed OI (3.4/100PY). Most common OIs: Candida (27%), Aspergillus (13.5%), CMV (13.5%) - lung & skin mostly. Risk factors: Pulse steroids, Dz activity (SLEDAI-2K ≥11) https://t.co/0zjDOnDCEh https://t.co/H7JZ56ItDY
Dr. John Cush @RheumNow ( View Tweet )
1 day 22 hours ago
Should You Use Low Dose Naltrexone? A recent review of 105 studies and 15 randomized controlled trials of LDN found that, across a range of disorders (chronic pain, autoimmune and neuroimmune disorders, gastrointestinal disease, dermatological conditions, post-infectious https://t.co/lmjJoGlFAZ
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
×